Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma.
Publication
, Journal Article
Reitman, ZJ
Published in: Pharmacogenomics
September 2014
Duke Scholars
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
September 2014
Volume
15
Issue
13
Start / End Page
1639 / 1641
Location
England
Related Subject Headings
- Protein Phosphatase 2C
- Phosphoprotein Phosphatases
- Pharmacology & Pharmacy
- Mutation
- Humans
- Glioma
- Gene Amplification
- Brain Stem
- Brain Neoplasms
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reitman, Z. J. (2014). Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma. Pharmacogenomics, 15(13), 1639–1641. https://doi.org/10.2217/pgs.14.123
Reitman, Zachary J. “Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma.” Pharmacogenomics 15, no. 13 (September 2014): 1639–41. https://doi.org/10.2217/pgs.14.123.
Reitman ZJ. Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma. Pharmacogenomics. 2014 Sep;15(13):1639–41.
Reitman, Zachary J. “Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma.” Pharmacogenomics, vol. 15, no. 13, Sept. 2014, pp. 1639–41. Pubmed, doi:10.2217/pgs.14.123.
Reitman ZJ. Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma. Pharmacogenomics. 2014 Sep;15(13):1639–1641.
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
September 2014
Volume
15
Issue
13
Start / End Page
1639 / 1641
Location
England
Related Subject Headings
- Protein Phosphatase 2C
- Phosphoprotein Phosphatases
- Pharmacology & Pharmacy
- Mutation
- Humans
- Glioma
- Gene Amplification
- Brain Stem
- Brain Neoplasms
- 3214 Pharmacology and pharmaceutical sciences